Author

Steve E. Pincus

Observed names: S E Pincus, S Pincus, S. Pincus, Steve Pincus

Institution: Elusys Therapeutics (United States)

Observed institutions: Tufts University, Brigham and Women's Hospital, Tufts Medical Center, Roswell Park Comprehensive Cancer Center, National Institutes of Health, The Royal Melbourne Hospital, State University of New York, Harvard University, Walter and Eliza Hall Institute of Medical Research, Morristown Medical Center, National Cancer Institute, Elusys Therapeutics (United States), Stony Brook University, University at Buffalo, State University of New York

OpenAlex ID: A5113433002

Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C

1986 · S E Pincus, D C Diamond, et al. · Journal of Virology · 172

PDF

A Canarypox Vector–Expressing Cytomegalovirus (CMV) Phosphoprotein 65 Induces Long‐Lasting Cytotoxic T Cell Responses in Human CMV‐Seronegative Subjects

2001 · Klara Berencsi, Zsofia Gyulai, et al. · The Journal of Infectious Diseases · 146

Cytotoxic T Lymphocyte (CTL) Responses to Human Cytomegalovirus pp65, IE1‐Exon4, gB, pp150, and pp28 in Healthy Individuals: Reevaluation of Prevalence of IE1‐Specific CTLs

2000 · Zsofia Gyulai, Valeria Endresz, et al. · The Journal of Infectious Diseases · 142

A Canarypox Vector Expressing Cytomegalovirus (CMV) Glycoprotein B Primes for Antibody Responses to a Live Attenuated CMV Vaccine (Towne)

1999 · Stuart P. Adler, Stanley A. Plotkin, et al. · The Journal of Infectious Diseases · 125

Capsid protein VP4 of poliovirus is N-myristoylated.

1987 · A V Paul, A Schultz, et al. · Proceedings of the National Academy of Sciences · 108

Production of guanidine-resistant and -dependent poliovirus mutants from cloned cDNA: mutations in polypeptide 2C are directly responsible for altered guanidine sensitivity

1986 · S E Pincus, E Wimmer · Journal of Virology · 108

Poxvirus-based vectors as vaccine candidates.

1990 · J Tartaglia, S Pincus, et al. · PubMed · 71

Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge

1991 · J Taylor, S Pincus, et al. · Journal of Virology · 68

PDF

A vipox virus-vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogens

1994 · E. Konishi, S. Pincus, et al. · Vaccine · 57

PDF

Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization

1999 · Valeria Endresz, Laszlo Kari, et al. · Vaccine · 56

Eosinophil activation by colony-stimulating factor in man: metabolic effects and analysis by flow cytometry

1983 · MA Vadas, G Varigos, et al. · Blood · 46

PDF

Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.

1995 · K A Foon, A R Oseroff, et al. · PubMed · 34

Safety and immunogenicity of recombinants based on the genetically-engineered vaccinia strain, NYVAC.

1994 · J Tartaglia, W I Cox, et al. · PubMed · 30

A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1)

2005 · A Repik, S E Pincus, et al. · Clinical & Experimental Immunology · 29

Squamous cell carcinoma in a family with dominant dystrophic epidermolysis bullosa: a molecular genetic study

1999 · A. M. Christiano, J. Crollick, et al. · Experimental Dermatology · 25

A DeImmunized chimeric anti-C3b/iC3b monoclonal antibody enhances rituximab-mediated killing in NHL and CLL cells via complement activation

2005 · Wu Peng, Xin Zhang, et al. · Cancer Immunology Immunotherapy · 20

First clinical trials of a new heteropolymer technology agent in normal healthy volunteers and patients with systemic lupus erythematosus: safety and proof of principle of the antigen-heteropolymer ETI-104

2004 · C Iking-Konert, S Stocks, et al. · Annals of the Rheumatic Diseases · 18

PDF

HTLV-Associated Diseases: Human Retroviral Infection and Cutaneous T-Cell Lymphomas

1997 · K. Fujihara, B. Goldman, et al. · Immunological Investigations · 10

Evaluation of Antigen-Based Heteropolymer for Treatment of Systemic Lupus Erythematosus in a Nonhuman Primate Model

2002 · S Pincus · Clinical Immunology · 8

Topical δ-aminolevulinic acid for photodynamic therapy of cutaneous carcinomas and cutaneous T cell lymphoma

1993 · SD Shanler, W Wan, et al. · Journal of Dermatological Science · 6

Purification of carp putative eosinophils on metrizamide gradients

1986 · M. Hendrick, A. DiNapoli, et al. · Journal of Fish Biology · 4

Treatment with an Anti-C3b/iC3b Monoclonal Antibody as an Adjuvant to Rituximab Enhances the Killing of Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia Cells.

2004 · Wu Peng, Xin Zhang, et al. · Blood · 1

1,25-dihydroxyvitamin D3 Is an Effective Therapeutic Agent for the Treatment of Psoriasis Vulgaris and Erythroderma Psoriasis

1988 · M.F. Holick, E.L. Smith, et al. · De Gruyter eBooks

Removal of digoxin from plasma using monoclonal anti-digoxin antibodies immobilized on agarose

1986 · Marius V. Brizgys, S Pincus, et al. · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States)

Eosinophil Activation by a Subspecies of Human Colony Stimulating Factor (csf), Csf-alpha

1982 · MA Vadas, George Varigos, et al. · FEDERATION PROCEEDINGS

Works count: 26

Citation count: 1,284

H-index: 17

I10-index: 18